Selective Growth Inhibition of Multidrug-Resistant CHO Cells by Monoclonal Antibody 265/F4
Author Information
Author(s): T. Efferth, B. Lathan, M. Voim
Primary Institution: German Cancer Research Centre, Institute of Experimental Pathology
Hypothesis
Can monoclonal antibody 265/F4 selectively inhibit the growth of multidrug-resistant CHO cells?
Conclusion
Monoclonal antibody 265/F4 and its conjugate with ricin-alpha chain effectively inhibit the growth of multidrug-resistant CHO cells.
Supporting Evidence
- MAb 265/F4 inhibited the growth of multidrug-resistant CHO-cells in a dose-dependent manner.
- Maximal effect (75% inhibition of growth) was observed at a concentration of 100 µg/ml MAb 265/F4 after a 7-day exposure.
- At a concentration of 3 µg/ml, the 265/F4-RAC immunotoxin reduced cell growth by 90% in resistant cells.
Takeaway
The study shows that a special antibody can help kill cancer cells that are resistant to many drugs, making it a potential treatment option.
Methodology
The study used sensitive and colchicine-resistant CHO cells to evaluate the growth-inhibitory effects of monoclonal antibody 265/F4 and its conjugate.
Limitations
The biochemical mechanism of the selective growth-inhibitory effect of MAb 265/F4 on multidrug-resistant CHO-cells is unclear.
Participant Demographics
Chinese hamster ovary (CHO) cells, both sensitive and colchicine-resistant.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website